Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rendu

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|October 1, 1987
Abnormal phosphoinositide metabolism and protein phosphorylation in platelets from a patient with the grey platelet syndromeF Rendu, P Marche, T Hovig, et al.
European Journal of Biochemistry|November 26, 1990
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reactionE Mazoyer, S Lévy-Toledano, F Rendu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolismE Arnaud, V Nicaud, O Poirier, et al.
Biochemical Pharmacology|April 15, 1989
Ajoene, the antiplatelet compound derived from garlic, specifically inhibits platelet release reaction by affecting the plasma membrane internal microviscosityF Rendu, D Daveloose, J C Debouzy, et al.
The Biochemical Journal|June 15, 1992
Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitorsC Bachelot, E Cano, F Grelac, et al.
FEBS Letters|July 14, 1999
Calpain controls the balance between protein tyrosine kinase and tyrosine phosphatase activities during platelet activationS Pain, A Monstero-Lastres, H Falet, et al.
The American Journal of Pathology|June 1, 1983
Evidence that abnormal platelet functions in human Chédiak-Higashi syndrome are the result of a lack of dense bodiesF Rendu, J Breton-Gorius, M Lebret, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1981
Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet functionS Levy-Toledano, J P Caen, J Breton-Gorius, et al.
American Journal of Hematology|January 1, 1978
Studies on a new variant of the Hermansky-Pudlak syndrome: qualitative, ultrastructural, and functional abnormalities of the platelet-dense bodies associated with a phospholipase A defectF Rendu, J Breton-Gorius, G Trugnan, et al.
British Journal of Pharmacology|December 1, 1996
Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregationJ L Donato, S Marcondes, E Antunes, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|October 1, 1987
Abnormal phosphoinositide metabolism and protein phosphorylation in platelets from a patient with the grey platelet syndromeF Rendu, P Marche, T Hovig, et al.
European Journal of Biochemistry|November 26, 1990
KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reactionE Mazoyer, S Lévy-Toledano, F Rendu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2000
Protective effect of a thrombin receptor (protease-activated receptor 1) gene polymorphism toward venous thromboembolismE Arnaud, V Nicaud, O Poirier, et al.
Biochemical Pharmacology|April 15, 1989
Ajoene, the antiplatelet compound derived from garlic, specifically inhibits platelet release reaction by affecting the plasma membrane internal microviscosityF Rendu, D Daveloose, J C Debouzy, et al.
The Biochemical Journal|June 15, 1992
Functional implications of tyrosine protein phosphorylation in platelets. Simultaneous studies with different agonists and inhibitorsC Bachelot, E Cano, F Grelac, et al.
FEBS Letters|July 14, 1999
Calpain controls the balance between protein tyrosine kinase and tyrosine phosphatase activities during platelet activationS Pain, A Monstero-Lastres, H Falet, et al.
The American Journal of Pathology|June 1, 1983
Evidence that abnormal platelet functions in human Chédiak-Higashi syndrome are the result of a lack of dense bodiesF Rendu, J Breton-Gorius, M Lebret, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1981
Gray platelet syndrome: alpha-granule deficiency. Its influence on platelet functionS Levy-Toledano, J P Caen, J Breton-Gorius, et al.
American Journal of Hematology|January 1, 1978
Studies on a new variant of the Hermansky-Pudlak syndrome: qualitative, ultrastructural, and functional abnormalities of the platelet-dense bodies associated with a phospholipase A defectF Rendu, J Breton-Gorius, G Trugnan, et al.
British Journal of Pharmacology|December 1, 1996
Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregationJ L Donato, S Marcondes, E Antunes, et al.
Pageof 10